Showing results (61-70 of 159) with videos related to
Sort By:
Pageof 16
BMC Immunology|March 23, 2010
Differential effects of Paclitaxel on dendritic cell functionJustin John, Mohammed Ismail, Catherine Riley, et al.Viruses|December 4, 2015
Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?Samantha Turnbull, Emma J West, Karen J Scott, et al.Oncolytic Virotherapy|August 12, 2016
Applications of coxsackievirus A21 in oncologyStephen Bradley, Adam D Jakes, Kevin Harrington, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapyMichael Gough, Marka Crittenden, Uma Thanarajasingam, et al.Clinical Medicine. Oncology|September 6, 2011
Oncolytic viruses: do they have a role in anti-cancer therapy?Robin J Prestwich, Fiona Errington, Kevin J Harrington, et al.International Journal of Cancer|May 31, 2007
CD40-mediated death and cytokine secretion in colorectal cancer: a potential target for inflammatory tumour cell killingNikolaos T Georgopoulos, Alison Merrick, Nigel Scott, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2008
Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapyPaul Hatfield, Alison E Merrick, Emma West, et al.NPJ Breast Cancer|July 24, 2025
The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancerMatthew Fenton, Miki Yoneyama, Erik Wennerberg, et al.Molecular Therapy. Oncology|October 15, 2024
APOBEC3B expression in 293T viral producer cells drives mutations in chimeric antigen receptors and reduces CAR T cell efficacyJack Swanson, Jason Tonne, Thanich Sangsuwannukul, et al.Journal for Immunotherapy of Cancer|March 26, 2022
CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanomaGalabina Bozhanova, Jehanne Hassan, Lizzie Appleton, et al.Pageof 16